A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo self-controlled phase I/II clinical study to evaluate the
safety, tolerability and preventive efficacy of different doses of AK3280 cream （AK3287 ）
after cicatrectomy in Patients with Hypertrophic Scar in China.